Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Gensetix, Inc. et al v. Baylor College Of Medicine et al
Case Number:
4:17-cv-01025
Court:
Nature of Suit:
Judge:
Firms
-
April 28, 2021
Baylor, Gensetix Agree To Drop Cancer Patent Fight For Good
Baylor College of Medicine and Gensetix Inc. have agreed to end their patent dispute over a cancer therapy, according to a recent filing.
-
February 22, 2019
Baylor Med School Denied Attys' Fees In Cancer IP Row
A Texas federal judge has rejected Baylor College of Medicine and its research partner's request to declare a cancer therapy patent infringement case exceptional so they could be awarded attorneys' fees as the self-declared prevailing party.
-
December 13, 2018
UT Can't Be Forced Into Patent Case, Ending Cancer IP Row
The University of Texas can't be forced to sue the Baylor College of Medicine for infringement of cancer therapy patents, and a drugmaker licensing those patents can't sue without UT by its side, a Texas federal judge has ruled, dooming the litigation.